126 related articles for article (PubMed ID: 36805091)
21. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
22. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
[TBL] [Abstract][Full Text] [Related]
23. Impaired functional connectivity of the thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state fMRI study.
Zhou B; Liu Y; Zhang Z; An N; Yao H; Wang P; Wang L; Zhang X; Jiang T
Curr Alzheimer Res; 2013 Sep; 10(7):754-66. PubMed ID: 23905993
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
Piersson AD; Ibrahim B; Suppiah S; Mohamad M; Hassan HA; Omar NF; Ibrahim MI; Yusoff AN; Ibrahim N; Saripan MI; Razali RM
PLoS One; 2021; 16(9):e0252883. PubMed ID: 34547018
[TBL] [Abstract][Full Text] [Related]
25. MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.
Raja R; Rosenberg GA; Caprihan A
Neuropharmacology; 2018 May; 134(Pt B):259-271. PubMed ID: 29107626
[TBL] [Abstract][Full Text] [Related]
26. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
[TBL] [Abstract][Full Text] [Related]
27. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
29. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
[TBL] [Abstract][Full Text] [Related]
30. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Epelbaum S; Burgos N; Canney M; Matthews D; Houot M; Santin MD; Desseaux C; Bouchoux G; Stroer S; Martin C; Habert MO; Levy M; Bah A; Martin K; Delatour B; Riche M; Dubois B; Belin L; Carpentier A
Alzheimers Res Ther; 2022 Mar; 14(1):40. PubMed ID: 35260178
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
Chandra A; Dervenoulas G; Politis M;
J Neurol; 2019 Jun; 266(6):1293-1302. PubMed ID: 30120563
[TBL] [Abstract][Full Text] [Related]
34. Differentiated Effective Connectivity Patterns of the Executive Control Network in Progressive MCI: A Potential Biomarker for Predicting AD.
Cai S; Peng Y; Chong T; Zhang Y; von Deneen KM; Huang L;
Curr Alzheimer Res; 2017; 14(9):937-950. PubMed ID: 28290245
[TBL] [Abstract][Full Text] [Related]
35. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
[TBL] [Abstract][Full Text] [Related]
36. Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI.
Teipel SJ; Wohlert A; Metzger C; Grimmer T; Sorg C; Ewers M; Meisenzahl E; Klöppel S; Borchardt V; Grothe MJ; Walter M; Dyrba M
Neuroimage Clin; 2017; 14():183-194. PubMed ID: 28180077
[TBL] [Abstract][Full Text] [Related]
37. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
[TBL] [Abstract][Full Text] [Related]
38. Blood-brain barrier breakdown in the aging human hippocampus.
Montagne A; Barnes SR; Sweeney MD; Halliday MR; Sagare AP; Zhao Z; Toga AW; Jacobs RE; Liu CY; Amezcua L; Harrington MG; Chui HC; Law M; Zlokovic BV
Neuron; 2015 Jan; 85(2):296-302. PubMed ID: 25611508
[TBL] [Abstract][Full Text] [Related]
39. Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.
Jahng GH; Xu S; Kim MJ
Med Phys; 2012 Oct; 39(10):6324-31. PubMed ID: 23039668
[TBL] [Abstract][Full Text] [Related]
40. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
